Once daily versus conventional dosing of pH-dependent mesalamine long-term to maintain quiescent ulcerative colitis: Preliminary results from a randomized trial

by Sunanda Kane, William Holderman, Peter Jacques, Todd Miodek
Published 2008-09-01